An Observational Study of Anticipatory Coping Behavior of Women for Chemotherapy-Induced Alopecia for Breast Cancer Treatment
- PMID: 36249621
- PMCID: PMC9557142
- DOI: 10.7759/cureus.29097
An Observational Study of Anticipatory Coping Behavior of Women for Chemotherapy-Induced Alopecia for Breast Cancer Treatment
Abstract
Background It is necessary to explore patients' expectations of chemotherapy-induced alopecia, anticipate reactions to alopecia, and how women intend to prepare for an altered body appearance. Studies regarding women's critical aspects of anticipatory coping behavior (anticipate reactions to alopecia and how women intend to prepare for a modified body appearance) towards hair loss and factors influencing it are sparse, especially from India. This study helped identify the factors influencing the anticipatory coping behavior toward chemotherapy-induced alopecia. Methodology This was a cross-sectional analytic study carried out for three months, including all breast cancer patients admitted for neo-adjuvant chemotherapy. Anticipatory coping behavior before and during each chemotherapy cycle period (minimum one cycle) was assessed using the World Health Organization scale. Study patients received two sets of questionnaires. The first question is asked before the start of chemotherapy, and the second is requested at least four weeks after completing the first chemotherapy. The first question included baseline demographic data, disease details, and awareness about hair loss. The second question had hair loss pattern, severity of cancer-induced alopecia, and rated the degree of alopecia in a visual analog scale score. Individual psychosocial and social factors associated with the anticipatory coping behavior were documented using a self-administered questionnaire. Results A total of 40 patients were included in the study. All of the participants reported anticipating hair loss. Five percent of the patients came to terms with the inevitability of hair loss. Around 22.5% of them became ready, 67.5% of the patients took control and 52.5% of the patients felt shame in front of society due to a lack of anticipatory behavior. About 47.5% of the participants felt that not being willing to wear a wig is a reason for deficient anticipatory coping behavior. Conclusion The study patients' main reasons for lack of anticipatory coping behavior were shame in society, insecure thoughts about the future, and unwillingness to live with a wig. It should be advised to such patients that losing hair is not a health problem (though it is an emotional issue), and clinicians can encourage them to use hats. Further multi-institutional prospective studies are required to assess the poor motivation of health care professionals to achieve target anticipatory coping behavior.
Keywords: alopecia; anticipatory coping behavior; breast cancer; chemotherapy; chemotherapy-induced alopecia.
Copyright © 2022, G et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
Anticipating an altered appearance: women undergoing chemotherapy treatment for breast cancer.Eur J Oncol Nurs. 2007 Dec;11(5):385-91. doi: 10.1016/j.ejon.2007.03.002. Epub 2007 May 18. Eur J Oncol Nurs. 2007. PMID: 17512251
-
Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy.Clin Breast Cancer. 2015 Oct;15(5):332-4. doi: 10.1016/j.clbc.2015.01.003. Epub 2015 Jan 26. Clin Breast Cancer. 2015. PMID: 25749072
-
Permanent Chemotherapy-Induced Alopecia in Patients with Breast Cancer: A 3-Year Prospective Cohort Study.Oncologist. 2019 Mar;24(3):414-420. doi: 10.1634/theoncologist.2018-0184. Epub 2018 Aug 17. Oncologist. 2019. PMID: 30120165 Free PMC article.
-
Anticipatory coping: taking control of hair loss.Clin J Oncol Nurs. 2011 Jun;15(3):311-5. doi: 10.1188/11.CJON.311-315. Clin J Oncol Nurs. 2011. PMID: 21624866 Review.
-
"Who am I?" A qualitative meta-synthesis of Chemotherapy-induced alopecia and body image perception in breast cancer patients.Support Care Cancer. 2023 Mar 28;31(4):237. doi: 10.1007/s00520-023-07704-8. Support Care Cancer. 2023. PMID: 36973593 Review.
Cited by
-
Fear of recurrence in postoperative lung cancer patients: Trajectories, influencing factors and impacts on quality of life.J Clin Nurs. 2024 Apr;33(4):1409-1420. doi: 10.1111/jocn.16922. Epub 2023 Oct 31. J Clin Nurs. 2024. PMID: 37908060 Free PMC article.
-
Chemotherapy induced alopecia in breast cancer patients: A monocentric prospective study.Breast Dis. 2024;43(1):251-255. doi: 10.3233/BD-240019. Breast Dis. 2024. PMID: 39213044 Free PMC article.
References
-
- Changes in self-concept and body image during alopecia induced cancer chemotherapy. Münstedt K, Manthey N, Sachsse S, Vahrson H. Support Care Cancer. 1997;5:139–143. - PubMed
-
- Chemotherapy-induced alopecia: a phenomenological study. Power S, Condon C. Cancer Nurs Pract. 2008;7:44–47.
-
- The role of hair loss in cancer identity: perceptions of chemotherapy-induced alopecia among women treated for early-stage breast cancer or ductal carcinoma in situ. Trusson D, Pilnick A. Cancer Nurs. 2017;40:0. - PubMed
-
- Impact of scalp cooling on chemotherapy-induced alopecia, wig use and hair growth of patients with cancer. van den Hurk CJ, van den Akker-van Marle ME, Breed WP, van de Poll-Franse LV, Nortier JW, Coebergh JW. Eur J Oncol Nurs. 2013;17:536–540. - PubMed
LinkOut - more resources
Full Text Sources